Short interest for HOOKIPA Pharma gives investors a sense of the degree to which investors are betting on the decline of HOOKIPA Pharma's stock. Short interest data is updated every two weeks.

HOOKIPA Pharma Stock (NASDAQ:HOOK), Short Interest Report

HOOKIPA Pharma

HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.

Cancer-Image by PDPics from Pixabay-

Biotech

News

Health Care

Movers

General

GILD

HOOK

RHHBY

HOOKIPA Pharma secures FDA clearance for its innovative HB-700 therapeutic vaccine targeting KRAS-mutated cancers. Learn about its broad impact on lung, colorectal, and pancreatic cancers, achieving significant milestones in collaboration and intellectual property.

Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday?

bz_pharma_briefs

RPTX

Roche study results show prolonged survival in R/R diffuse large B-cell lymphoma patients treated with Columvi (glofitamab) + GemOx vs. Rituxan + GemOx.

Roche&#39;s Lymphoma Drug With Chemo Extends Survival In Pretreated Patients

Roche

Large Cap

Contracts

Repare Therapeutics regains global rights to camonsertib (RP-3500) after terminating collaboration with Roche. $40M milestone achieved.

Roche Terminates Cancer Drug Pact With Repare Therapeutics, Its Second Walkout Within A Month

HOOKIPA Pharma Inc

Hooker Furnishings Corporation - Common Stock

Hooker Furnishings Corp

Tesla Inc&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) head of Cybertruck manufacturing Renjie Zhu has resigned from the company, joining the long list of senior executives to leave as company CEO&nbsp;Elon Musk&nbsp;seeks to&nbsp;<a href="https://www.benzinga.com/news/24/04/38244436/breaking-tesla-said-to-be-laying-off-over-14-000-employees" target="_blank" rel="noreferrer noopener">downsize the company&#8217;s workforce.</a>
What Happened:&nbsp; Zhu took to LinkedIn to announce his departure from the electric vehicle giant.&nbsp;
&#8220;After triumphing the epic launch of [the] Cybertruck program and ramping the volume production line to the steady 1K/W throughput orbit for the past 16 months in GFTX, also 7 weeks after the 5th Tesla-versary, my adventure with this great company has come to an end,&#8221; Zhu wrote. Zhu joined Tesla in 2019 and launched the Cybertruck program at Giga Texas in January 2023, as per his LinkedIn profile.
Tesla started delivering the Cybertruck in late November. During Tesla&#8217;s first-quarter earnings call in April, a company executive confirmed that it made 1000 vehicle units in a week. The company intends to scale production to 250,000 units annually starting in 2025.
Zhu's departure adds him to a growing list of senior executives who have left Tesla in recent weeks, including Senior Director of Charging Infrastructure&nbsp;Rebecca Tinucci, Director of New Product Introduction&nbsp;Daniel Ho, Senior Vice President of Powertrain and Energy Engineering&nbsp;Drew Baglino, and Vice President of Public Policy and Business Development&nbsp;Rohan Patel.
&#8220;Now it's time to start a new journey, like a Falcon 9 back to the base, to refuel and prepare for next launch,&#8221; Zhu wrote in his post, referring to the reusable Falcon 9 rocket made by Tesla CEO Elon Musk&#8216;s private company SpaceX. It is unclear if Zhu was laid off or resigned out of personal choice.
Why It Matters: Last month, Tesla announced plans to cut costs through a <a href="https://www.benzinga.com/news/24/04/38516190/elon-musk-cracks-whip-harder-2-more-senior-tesla-execs-reportedly-exit-as-ceo-demands-absolutely-har" target="_blank" rel="noreferrer noopener">10% workforce reduction</a>, impacting an estimated 14,000 employees. These layoffs reflect broader challenges facing the company, including declining sales and pricing pressures.
For the first quarter, Tesla reported revenue of $21.3 billion, down from the $23.33 billion reported a year earlier. This is the first time the company's quarterly&nbsp;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38398667/tesla-bulls-praise-musks-q1-earnings-call-see-ev-giant-on-collision-course-with-ube" target="_blank" rel="noreferrer noopener">revenue has fallen</a>&nbsp;since the pandemic in 2020. Tesla's net profit stood at $1.13 billion, falling 55% from $2.51 billion a year earlier.
Price Action:&nbsp;Tesla stock closed 2% higher on Monday at $171.89 and gained 0.5% after hours. The stock is down 30.8% year-to-date, according to data&nbsp;<a href="https://pro.benzinga.com/dashboard" target="_blank" rel="noreferrer noopener">from Benzinga Pro.</a>
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="http://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link</a>.
Read More: <a href="https://www.benzinga.com/news/24/05/38807360/elon-musks-spacex-reportedly-leaves-trail-of-unpaid-bills-worth-at-least-2-5m-amid-texas-expansion">Elon Musk&#8217;s SpaceX Reportedly Leaves Trail Of Unpaid Bills Worth At Least $2.5M Amid Texas Expansion</a>
Photo via Shutterstock

Management

Tech

TSLA

Another Tesla Exec Departs As Musk Downsizes: Cybertruck Manufacturing Head Marks End Of 'Adventure With This Great Company'

Earnings

FLUT

Flutter Entertainment Reports Q1 Revenue Of $3.397B Up From $2.918B YoY, Adjusted EPS $0.10 Down From $0.69 YoY

Positive Financial Outlook &amp; Fiscal 2024 Guidance:
The Company continues to anticipate revenue of approximately $65-75 million for the fiscal year ending September 30, 2024 (&quot;FY 2024&quot;). Approximately $20 million of this anticipated revenue is dependent on customers&#39; new distribution center sites. Any delays in the startup of these sites may lead to a proportion of revenue moving into the subsequent fiscal year. The Company expects to have further clarity on firm delivery dates for these sites over the next several months.
The annual revenue forecast takes into consideration revenue from already delivered orders, the Company&#39;s current purchase order backlog, which as of May 13, 2024 is over $43 million, in addition to anticipated new orders based on historical patterns and additional demand communicated to the Company, but not yet provided as a purchase order. This guidance is subject to change and is made barring any unforeseen circumstances. See &quot;Forward-Looking Statements&quot;.

Guidance

ELVA

Electrovaya Continues To Anticipate 2024 Revenue Of $65M-75M Vs. $72.7M Consensus

Electrovaya (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELVA#NASDAQ">ELVA</a>) reported quarterly sales of $10.70 million which missed the analyst consensus estimate of $17.05 million by 37.27 percent. This is a 26.27 percent increase over sales of $8.47 million the same period last year.

Electrovaya Q2 Sales $10.70M Miss $17.05M Estimate

PACS Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PACS#NYSE">PACS</a>) reported quarterly earnings of $0.38 per share which beat the analyst consensus estimate of $0.30 by 26.67 percent. This is a 31.03 percent increase over earnings of $0.29 per share from the same period last year. The company reported quarterly sales of $934.72 million which beat the analyst consensus estimate of $892.97 million by 4.68 percent. This is a 31.94 percent increase over sales of $708.44 million the same period last year.

PACS

PACS Group Q1 EPS $0.38 Beats $0.30 Estimate, Sales $934.72M Beat $892.97M Estimate

Gold Royalty (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GROY#AMEX">GROY</a>) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported $2.89 million in sales this quarter. This is a 277.31 percent increase over sales of $767.00 thousand the same period last year.

GROY

Gold Royalty Q1 EPS $(0.01), Inline, Sales $2.89M Up From $767.00K YoY

Gryphon Digital Mining (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRYP#NASDAQ">GRYP</a>) reported quarterly losses of $(0.36) per share. This is a 28.57 percent decrease over losses of $(0.28) per share from the same period last year. The company reported $7.49 million in sales this quarter. This is a 47.56 percent increase over sales of $5.08 million the same period last year.

GRYP

Gryphon Digital Mining Q1 EPS $(0.36) Down From $(0.28) YoY, Sales $7.49M Up From $5.08M YoY

While the much-touted Dencun Upgrade reduced the cost of using Ethereum&#8217;s (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) Layer-2 solutions, it also rendered Ethereum inflationary, raising concerns about its price impact.&nbsp;
What Happened: Ethereum's total supply surged to its highest level in more than two months, according to Julio Moreno, Head of Research at analytics firm CryptoQuant. He attributed the steady increase <a href="https://www.benzinga.com/markets/cryptocurrency/24/03/37667987/ethereum-dencun-upgrade-drops-layer-2-fees-by-99">to the Dencun Upgrade</a>, which was executed in mid-March.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Ethereum supply growth continues to accelerate and total supply is now at the highest level since March 6. The Dencun upgrade had the effect of lowering transactions fees, but also made ETH inflationary again. EHT will need 3x-4x more network activity to be deflationary again. <a href="https://t.co/9gK9Xepodk">pic.twitter.com/9gK9Xepodk</a>
&mdash; Julio Moreno (@jjcmoreno) <a href="https://twitter.com/jjcmoreno/status/1790033161214136681?ref_src=twsrc%5Etfw">May 13, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
"The Dencun upgrade had the effect of lowering transaction fees, but also made ETH inflationary again," Moreno stated. "ETH will need 3x-4x more network activity to be deflationary again."
The technical update resulted in a sharp drop in fees charged on Ethereum scaling solutions, including Arbitrum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">ARB</a>) and Polygon (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/matic/usd">MATIC</a>).&nbsp;
However, because Ethereum and its Layer-2 solutions burn a portion of transaction fees, the upgrade resulted in a significant reduction in Ethereum burned, which is the supply that gets permanently removed from circulation.
Why It Matters: &nbsp;As per the fundamentals of scarcity economics, a steady drop in the supply of an asset could lead to its value appreciation, provided demand catches up.&nbsp;
Much of the cryptocurrency market, including bellwether Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), has aggressively marketed its deflationary character to attract investors from mainstream markets.
Ethereum, too, has broadly remained deflationary in recent years, witnessing a 0.205 drop in supply since The Merge, <a href="https://ultrasound.money/">according </a>to ultra sound money.
However, the Dencun Upgrade has slowed down the deflation rate, with a 0.584% increase over the past 30 days.&nbsp;
The supply increase could concern Ethereum investors as they look for bullish catalysts in a market that has slackened over the past month or so.
Price Action: At the time of writing, Ethereum was trading at $2,933.43, following a 0.25% gain in the last 24 hours, according to <a href="https://pro.benzinga.com/">data from Benzinga Pro</a>. The second-largest cryptocurrency was down nearly 6% over the month.
Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38806925/pepe-becomes-hot-commodity-on-roaring-kitty-phenomenon-analyst-says-the-coin-should-be-on-">Pepe Becomes Hot Commodity on &#8216;Roaring Kitty&#8217; Phenomenon: Analyst Says The Coin Should Be On Your Radar</a>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

$ARB

$BTC

$ETH

$MATIC

The Dencun Dilemma: Can Lower Fees Derail Ethereum's Deflationary Ambitions And Dampen Prospects Of A Price Surge?

ZENV

Zenvia 2024 Guidance: Expects Revenue OF BRL$930M-BRL$970M, Adjusted Gross Margin Of 42%-45%, And Normalized EBITDA OF BRL$120M-BRL$140M

Zenvia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZENV#NASDAQ">ZENV</a>) reported quarterly sales of BRL 217.014 million which missed the analyst consensus estimate of BRL 237.260 million by 8.53 percent. This is a 24.09 percent increase over sales of BRL 174.886 million the same period last year.

Earnings Misses

Zenvia Q4 Sales BRL 217.014M Miss BRL 237.260M Estimate, Normalized EBITDA BRL 29.5M Up From BRL 23M YoY

Mark Zuckerberg, the CEO of&nbsp;Meta Platforms Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), is reportedly set&nbsp;to celebrate his 40th birthday on his new superyacht, Launchpad, in Panama.
What Happened: The 118-meter yacht, built by Dutch shipyard Feadship, has been the subject of speculation in the yachting world for months, with many believing Zuckerberg to be the owner,&nbsp;<a href="https://www.businessinsider.com/mark-zuckerberg-may-celebrate-40th-birthday-brand-new-superyacht-launchpad-2024-5?IR=T">reported</a>&nbsp;Business Insider.
Launchpad, which&nbsp;arrived in Panama on Monday,&nbsp;has been predominantly moored in Fort Lauderdale, Florida, since its&nbsp;maiden voyage across the Atlantic&nbsp;in March. According to a private jet tracker, Zuckerberg&#8217;s plane also touched down in Panama on Monday, and judging by his Instagram activity, it appears he was on board.
See Also:&nbsp;<a href="https://www.benzinga.com/news/24/05/38789719/beating-us-sanctions-chinese-scientists-achieve-mass-production-of-optical-chips-at-low-cost?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Beating US Sanctions, Chinese Scientists Achieve Mass Production Of Optical Chips At Low Cost</a>
<figure class="wp-block-image size-large"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/14015819/Screenshot-2024-05-14-at-11.28.07%E2%80%AFAM-1024x867.png" alt="" class="wp-image-336268" /></figure>
Connecting the dots, considering various clues tying Zuckerberg to the yacht, it seems reasonable to conclude that the Meta CEO is probably starting his new decade aboard his newly acquired vessel, the report noted. 
Little is known about the&nbsp;luxury yacht, initially&nbsp;built for a sanctioned Russian&nbsp;businessman before being&nbsp;handed over to the Dutch&nbsp;government. The&nbsp;final purchase price is unknown,&nbsp;but it is estimated to be in the&nbsp;nine figures upfront and six&nbsp;figures annually for maintenance.
Launchpad is believed to have a helipad, a swimming pool on the main deck, and facilities such as a gym, spa, movie room, and a garage for his hydrofoil.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="598" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/14020315/extra-large-1024x598.jpeg" alt="" class="wp-image-336279" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/14020315/extra-large-1024x598.jpeg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/14020315/extra-large-300x175.jpeg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/14020315/extra-large-768x449.jpeg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/14020315/extra-large-1536x897.jpeg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/14020315/extra-large.jpeg 1621w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Image credit: Ruben Griffioen / SuperYacht Times</figcaption></figure>
Why It Matters: Zuckerberg&#8217;s birthday celebration on a superyacht comes after a period of transformation for the tech mogul. In an interview with Forbes in September 2023, <a href="https://www.benzinga.com/news/23/09/34949713/from-evil-mark-to-great-philanthropist-meta-ceo-zuckerberg-opts-for-a-bill-gates-style-metamorphosis">Zuckerberg expressed his desire to follow</a> in the footsteps of Microsoft co-founder&nbsp;Bill Gates, aiming to mature personally and professionally.
Meanwhile, Zuckerberg&#8217;s net worth has also continued to soar. Last year, his net worth&nbsp;<a href="https://www.benzinga.com/general/24/05/38643768/mark-zuckerbergs-net-worth-grew-by-84-billion-in-2023-but-his-salary-was-just-1">increased by $84 billion</a>, making him the fourth-richest person in the world.
According to the Bloomberg Billionaire Index, Zuckerberg&#8217;s total net worth at the moment is $167 billion.
Photo courtesy: Brian Solis via Flickr
Check out more of&nbsp;Benzinga's&nbsp;Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:&nbsp;<a href="https://www.benzinga.com/news/24/05/38779672/whats-new-in-consumer-tech-world-last-week-news-that-you-should-know-may-5-may-11-2024?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">What&#8217;s New In Consumer Tech World Last Week? News That You Should Know (May 5-May 11, 2024)</a>
Disclaimer:&nbsp;This content was partially produced with&nbsp;the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was&nbsp;reviewed and published by Benzinga editors.

Media

Mark Zuckerberg Turns 40 In Style As Meta CEO Reportedly Celebrates Birthday Party On $300M Superyacht In Panama

Belite Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLTE#NASDAQ">BLTE</a>) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.28) by 3.57 percent. This is a 18.18 percent increase over losses of $(0.33) per share from the same period last year.
As of March 31, 2024, the Company had $95.5 million in cash and U.S treasury bills.

Earnings Beats

BLTE

Belite Bio Q1 2024 GAAP EPS $(0.27) Beats $(0.28) Estimate

<ul>
<li>First preclinical data set for IPH45, a pre-IND anti-Nectin-4 Antibody Drug Conjugate, presented as an oral presentation at AACR 2024</li>
<li>Progression of Sanofi-developed NK Cell Engager SAR443579/IPH6101 to Phase 2 in blood cancers</li>
<li>Five ASCO Annual Meeting 2024 abstracts:
<ul>
<li>Final TELLOMAK Phase 2 data for lacutamab in Mycosis Fungoides</li>
<li>Two posters on IPH6501, Innate&#39;s second generation ANKET&reg;&nbsp;in B‑cell Non-Hodgkin&#39;s Lymphoma</li>
<li>AstraZeneca to present poster on updated results for monalizumab from Phase 2 stage III unresectable NSCLC trial</li>
<li>Monalizumab SCLC Phase 2 MOZART trial poster</li>
</ul>
</li>
<li>Cash position of &euro;113.9 million1&nbsp;as of March 31, 2024 (not including the &euro;4.0 million payment to be received from Sanofi), anticipated cash runway into end 2025</li>
</ul>

IPHA

Innate Pharma Reported Q1 Revenue Of €6.6M Down From €26M YoY; Cash Position Of €113.9M

The global supply of high-performance memory chips is expected to remain constrained throughout 2024, driven by the soaring demand for artificial intelligence technology.
What Happened: The supply of high-end memory chips is projected to remain tight due to the exponential demand for AI technology, as per a CNBC <a href="https://www.cnbc.com/2024/05/14/ai-boom-to-keep-supply-of-high-end-memory-chips-tight-through-2024.html">report</a> on Tuesday. This is likely to affect the supply of these chips for the rest of 2024 and well into 2025.
Leading memory chip suppliers, including SK Hynix and Micron Technology Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>), are already facing a shortage of high-bandwidth memory chips for 2024, with the stock for 2025 also nearly depleted.
″We expect the general memory supply to remain tight throughout 2024," Kazunori Ito, director of equity research at Morningstar said in a report.
See Also: <a href="https://www.benzinga.com/markets/equities/24/05/38777196/amid-nvidia-craze-jim-cramer-sees-a-chip-stock-not-on-anyones-radar-about-to-break-out-heres-wha?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Amid Nvidia Craze, Jim Cramer Sees A Chip Stock &#8216;Not On Anyone&#8217;s Radar&#8217; About To Break Out: Here&#8217;s What He Said</a>
The demand for AI chipsets has significantly boosted the high-end memory chip market, benefiting major players such as Samsung Electronics (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SSNLF#OTC">SSNLF</a>) and SK Hynix, the top two memory chipmakers globally.
"The manufacturing of these chips are more complex and ramping up production has been difficult. This likely sets up shortages through the rest of 2024 and through much of 2025," said William Bailey, director at Nasdaq IR Intelligence.
 Chip manufacturers are competing intensely to produce cutting-edge memory chips to capitalize on the AI surge.
In a recent press conference, SK Hynix announced its initiation of mass production for the latest HBM chips, the 12-layer HBM3E, starting in the third quarter. Samsung Electronics, on the other hand, plans to commence mass production in the second quarter, having already shipped samples of this advanced chip, marking an industry-first achievement.
"Currently Samsung is ahead in 12-layer HBM3E sampling process. If they can get qualification earlier than its peers, I assume it can get majority shares in end-2024 and 2025," said SK Kim, executive director and analyst at Daiwa Securities.
Why It Matters: The global race to control chip supply is intensifying, with China recently <a href="https://www.benzinga.com/markets/asia/24/05/38800273/chinas-semiconductor-spending-tops-us-with-142b-commitment-global-chip-race-heats-up">overtaking the U.S.</a> in semiconductor spending. This has become a key focus for Western governments in their efforts to compete with China in the industry.
Additionally, the U.S. and China are set to discuss the potential risks of advanced AI in <a href="https://www.benzinga.com/news/24/05/38783544/us-china-to-discuss-ai-risks-in-geneva-will-washingtons-policies-be-up-for-negotiation">upcoming talks in Geneva</a>. The talks will explore ways to mitigate the potential dangers of this emerging technology, which is driving the demand for high-end memory chips.
Meanwhile, NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) is expected to continue delivering <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/05/38798378/hsbc-analyst-sees-nvidia-stock-climbing-another-50-on-strong-pricing-power-ai-roadm">strong pricing power</a> and upside surprises through fiscal-year 2026, according to HSBC Global Research. This is likely to further fuel the demand for high-end memory chips.
Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38780639/bitcoin-ethereum-dogecoin-trade-mixed-after-turbulent-week-analyst-says-king-crypto-can-ri?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Bitcoin, Ethereum, Dogecoin Trade Mixed After Turbulent Week: Analyst Says King Crypto Can Rise To $76K Level If It Reclaims This Crucial Support</a>
Image Via Shutterstock 
<hr class="wp-block-separator has-alpha-channel-opacity" />
Engineered by Benzinga Neuro, Edited by <a href="https://www.benzinga.com/topic/Kaustubh-Bagalkote" target="_blank" rel="noreferrer noopener">Kaustubh Bagalkote</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />
The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Learn more.</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />

Global

NVDA

SSNLF

High-Performance Memory Chip Supply To Stay Tight In 2024 Amid Surging AI Demand, Major Manufacturers Face Shortages

Sony Group Corporation American Depositary Shares

SONY

Sony Group Provides Fiscal 2024 Outlook: Expects Sales Of ¥12.31T ($84.89B); Operating Margin Of 10.4%, And Adjusted EBITDA Of ¥1.93T ($13.31B)

Macro Economic Events

Econ #s

Economics

INDA

India Wholesale Price Index (WPI) Inflation (YoY) For April 1.26% Vs. 1.00% Est.; 0.53% Prior

Over two dozen companies have reportedly filed over 70 liens against sites developed by billionaire entrepreneur&nbsp;<a target="_blank" href="https://www.benzinga.com/news/24/05/38782522/spacex-starship-likely-to-fly-for-4th-time-next-month-as-elon-musk-reaffirms-new-goals" rel="noreferrer noopener">Elon Musk</a><a target="_blank" href="https://www.benzinga.com/news/24/05/38782522/spacex-starship-likely-to-fly-for-4th-time-next-month-as-elon-musk-reaffirms-new-goals" rel="noreferrer noopener">&#8216;s&nbsp;</a><a target="_blank" href="https://www.benzinga.com/news/24/05/38782522/spacex-starship-likely-to-fly-for-4th-time-next-month-as-elon-musk-reaffirms-new-goals" rel="noreferrer noopener">SpaceX</a>&nbsp;and its contractors since 2019 due to unpaid bills.&nbsp;
What Happened:&nbsp;According to Reuters, several construction companies filed liens against SpaceX properties after they failed to receive payment for their services.&nbsp;
Since 2019, more than two dozen companies have reportedly lodged 72 liens against sites developed by SpaceX and its contractors, seeking payments totaling over $2.5 million. 
It remains unclear whether these outstanding amounts&nbsp;are owed&nbsp;by SpaceX&nbsp;itself or any of its commissioned contractors.&nbsp;
Among&nbsp;these businesses, some&nbsp;have expressed reluctance to engage in future&nbsp;SpaceX-related projects.&nbsp;Hydroz Energy Services LLC, an excavating&nbsp;business, is owed just $19,214 by SpaceX, a modest sum compared to the rocket manufacturer&#8217;s&nbsp;<a target="_blank" href="https://www.benzinga.com/news/23/12/36249896/spacex-worth-180-billion-now-musk-owned-companys-value-tops-boeing-lockheed-martin-disney-verizon-ib" rel="noreferrer noopener">valuation of $180 billion</a>&nbsp;as of a tender offer in December.&nbsp;
Of the 72 liens, at least 41&nbsp;were filed&nbsp;this year, and some have&nbsp;been resolved.&nbsp;Martin Marietta Materials Inc., a construction supply giant based in North Carolina, received $557,611 it claimed in March 2023, two months after filing its lien.&nbsp;
However, many liens remain unresolved, including one filed by Texas-based materials supplier CMC Construction Services for an outstanding bill of $129,592.&nbsp;
Why It Matters: Musk, currently the third richest person globally according to Forbes&#8217; real-time billionaires list, faces increasing scrutiny due to these financial issues.&nbsp;
After he acquired Twitter, now X, in 2022, Musk encountered a barrage of lawsuits from contractors alleging unpaid bills.&nbsp;Additionally,&nbsp;as the CEO of publicly-listed EV giant&nbsp;Tesla Inc., with a market cap of $548.19 billion as of the latest close, Musk&#8217;s financial responsibilities extend beyond SpaceX.
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="http://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link</a>.
Read More:&nbsp;<a href="https://www.benzinga.com/news/24/05/38782522/spacex-starship-likely-to-fly-for-4th-time-next-month-as-elon-musk-reaffirms-new-goals" target="_blank" rel="noreferrer noopener">SpaceX Starship Likely To Fly For 4th Time Next Month As Elon Musk Reaffirms New Goals</a>
Photo by Angga Budhiyanto on Shutterstock

SPACE

Elon Musk's SpaceX Reportedly Leaves Trail Of Unpaid Bills Worth At Least $2.5M Amid Texas Expansion

Patients using Novo Nordisk&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NONOF#OTC">NONOF</a>) obesity treatment, Wegovy, have reportedly maintained an average weight loss of 10% over a four-year period, as per data revealed by the company on Tuesday. This information was shared at the European Congress on Obesity in Venice, Italy.
What Happened: The data, derived from a large-scale study, most of which was published last year, could potentially bolster Novo&#8217;s case for Wegovy as it attempts to convince insurers and governments to cover the cost of the drug, countering the perception of it being merely a lifestyle drug, Reuters reported.
&#8220;This is the longest study we&#8217;ve conducted so far of semaglutide for weight loss,&#8221; stated Martin Holst Lange, Novo&#8217;s head of development. 
See Also: <a href="https://www.benzinga.com/general/health-care/24/05/38763450/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Benzinga&#8217;s &#8216;Stock Whisper&#8217; Index: 5 Stocks Investors Secretly Monitor But Don&#8217;t Talk About Yet</a>
The trial involved 17,604 patients and tested Wegovy not for weight loss, but for its heart protective benefits for overweight and obese patients with preexisting heart disease but not diabetes. Participants were not required to track diet and exercise as it was not an obesity study.
Why It Matters: Despite s<a href="https://www.benzinga.com/markets/equities/24/05/38575293/demand-soars-for-novo-nordisks-weight-loss-drug-wegovy-despite-supply-constraints-and-eli-lilly-">upply constraints and competition</a> from Eli Lilly, the demand for Wegovy has been on the rise. The drug&#8217;s sales more than doubled to 9.38 billion kroner ($1.35 billion) in the first quarter, although this figure fell short of analysts&#8217; estimates due to pricing pressure.
Tesla CEO <a href="https://www.benzinga.com/news/24/05/38634420/ozempic-ftw-elon-musk-touts-novo-nordisks-blockbuster-drug-as-solution-to-childhood-obesity-problem">Elon Musk recently endorsed</a> Novo Nordisk&#8217;s Ozempic, a GLP-1 agonist primarily prescribed to manage Type 2 diabetes, and <a href="https://www.benzinga.com/news/24/05/38634420/ozempic-ftw-elon-musk-touts-novo-nordisks-blockbuster-drug-as-solution-to-childhood-obesity-problem">sparked a conversation </a>about childhood obesity and potential solutions.
On the other hand, Denmark&#8217;s healthcare authority has decided to <a href="https://www.benzinga.com/general/biotech/24/05/38554472/setback-for-novo-nordisk-denmark-shifts-prescription-guidelines-favoring-cost-effective-alternati">favor less expensive drugs for type 2 diabetes patients</a>, impacting the prescription of costlier GLP-1 drugs such as Novo Nordisk&#8217;s Ozempic. This decision is expected to affect nearly half of all current GLP-1 drug users, who may switch to cheaper alternatives.
Price Action: On Monday, Novo Nordisk closed 3.09% higher on NYSE at $132.39, according to <a href="https://pro.benzinga.com">Benzinga Pro</a>.
Read Next: <a href="https://www.benzinga.com/government/24/05/38782353/barbarism-aoc-unleashes-fury-on-us-healthcare-system-as-people-are-choosing-between-medicine-and-ren?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">&#8216;Barbarism:&#8217; AOC Unleashes Fury On US Healthcare System As People Are &#8216;Choosing Between Medicine And Rent&#8217;</a>
Image Via Shutterstock
<div style="font-family: 'Lato', sans-serif">
<div>
<hr style="border: 0;height: 5px;background: #225aa9" />
<div style="background-color: #f5f5f5;background-position: center;background-size: cover;justify-content: center"></div>

 Engineered by Benzinga Neuro, Edited by 
 <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Pooja Rajkumari</a> 
 
 
<hr style="border: 0;height: 1px;background: #225aa9" />

 The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. 
 <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Learn more.</a>
 
<hr style="border: 0;height: 5px;background: #225aa9" />
 </div>
</div>

NONOF

Novo Nordisk's Wegovy Delivers: Long-Term Study Shows Sustained Weight Loss As Drugmaker Tries To Woo Insurers And Governments

Sony Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>) reported quarterly earnings of $1.03 per share which beat the analyst consensus estimate of $0.79 by 31.01 percent. This is a 54.48 percent increase over earnings of $0.67 per share from the same period last year. The company reported quarterly sales of $23.46 billion which beat the analyst consensus estimate of $19.20 billion by 22.18 percent. This is a 56.20 percent increase over sales of $15.02 billion the same period last year.

Sony Group Q4 EPS $1.03 Beats $0.79 Estimate, Sales $23.46B Beat $19.20B Estimate

Elon Musk&#8216;s Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) is likely to experience a significant decline in its stock value, according to a prominent investor. The investor&#8217;s prediction is based on the company&#8217;s recent developments and its future prospects.
What Happened: Danny Moses, a well-known investor and a long-time critic of Tesla, has forecasted a substantial drop in the company&#8217;s stock price, <a href="https://www.cnbc.com/2024/05/12/big-short-trader-danny-moses-warns-tesla-is-vulnerable-to-70percent-drop.html">reported</a> CNBC&#8217;s &#8220;Fast Money.&#8221;&nbsp;
Moses, who is known for his role in the &#8220;Big Short,&#8221; expects Tesla&#8217;s stock to plummet by 70% to $50 from its current $171.
"Everything is kind of falling apart in their core business. He's pointing everybody to robotaxis and AI and autonomy. It's really become a ‘show me' story in terms of if it's an auto company, and I think people are going to start to lose patience over time here for what the company is going to be,&#8221; Moses said. 
Moses attributes this anticipated decline to the company&#8217;s robotaxi and artificial intelligence initiatives, which he believes are masking fundamental business issues. He also points to the distractions caused by CEO Elon Musk&#8217;s focus on these technologies, despite mounting challenges in the company&#8217;s core operations.
See Also: <a href="https://www.benzinga.com/markets/cannabis/24/05/36913413/why-do-americans-still-buy-non-legal-weed-illicit-cannabis-sales-3-times-higher-than-legal-marij?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Why Do Americans Still Buy Non-Legal Weed? Illicit Cannabis Sales 3 Times Higher Than Legal Marijuana Sal</a>
Despite a brief stock price increase following Musk&#8217;s reaffirmation of the robotaxi and AI plans during the first quarter earnings call, Moses remains skeptical. He believes that these announcements are diverting attention from the company&#8217;s underlying problems.
The company is also under investigation by the Department of Justice for potentially misleading consumers and investors about the self-driving capabilities of its vehicles.
Moses, while maintaining Tesla as his main short position, praised another autonomous driving company named Wayve. This firm had recently secured $1 billion in funding from notable investors like Nvidia and Bill Gates.
Why It Matters: Tesla&#8217;s stock has been under scrutiny for various reasons. The company is facing challenges in the uptake of its Full Self-Driving technology, with <a href="https://www.benzinga.com/markets/equities/24/05/38805961/elon-musks-tesla-faces-fsd-uptake-challenge-as-only-2-of-free-trial-users-subscribe-gary-black-t">only 2% of free trial users</a> opting for the subscription, raising concerns about the future of the technology.
Additionally, Tesla has been experiencing significant <a href="https://www.benzinga.com/markets/equities/24/05/38796493/teslas-fire-hire-musk-brings-back-some-laid-off-supercharger-team-employees">changes in its workforce</a>, with reports of laid-off Supercharger team members being rehired.
Despite these challenges, the company is making significant strides in <a href="https://www.benzinga.com/markets/asia/24/05/38782261/china-greenlights-another-big-tesla-factory-this-time-for-megapack-project">its global expansion</a>, with China recently approving a new megafactory project, and its Cybertrucks gaining traction in the used car market. 
Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38780639/bitcoin-ethereum-dogecoin-trade-mixed-after-turbulent-week-analyst-says-king-crypto-can-ri?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Bitcoin, Ethereum, Dogecoin Trade Mixed After Turbulent Week: Analyst Says King Crypto Can Rise To $76K Level If It Reclaims This Crucial Support</a>
Image Via Shutterstock 
<hr class="wp-block-separator has-alpha-channel-opacity" />
Engineered by Benzinga Neuro, Edited by <a href="https://www.benzinga.com/topic/Kaustubh-Bagalkote" target="_blank" rel="noreferrer noopener">Kaustubh Bagalkote</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />
The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Learn more.</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />

Equities

Analyst Ratings

'Big Short' Fame Investor Expects Elon Musk's Tesla Shares To Plunge 70%: 'People Are Going To Start To Lose Patience'

Hookipa to receive $10M from Roche as FDA clears cancer trial

Roy Buchanan, an analyst from JMP Securities, reiterated the Buy rating on Hookipa Pharma (HOOK – Research Report). The associated price target rem...

Buy Rating Affirmed for Hookipa Pharma Amidst Promising Pipeline and Strategic Advancements

Hookipa Pharma Inc (HOOK) has shared an update. HOOKIPA Pharma Inc. has unveiled the design for a crucial Phase 2/3 clinical trial of HB-200 in com...

Hookipa Pharma Announces Major HB-200 Clinical Trial Design

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Hookipa Pharma (HOOK – Research Report), Praxis Prec...

Analysts Offer Insights on Healthcare Companies: Hookipa Pharma (HOOK), Praxis Precision Medicines (PRAX) and Blueprint Medicines (BPMC)

In a report released today, Asthika Goonewardene from Truist Financial maintained a Buy rating on Hookipa Pharma (HOOK – Research Report). The comp...

Truist Financial Remains a Buy on Hookipa Pharma (HOOK)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Edwards Lifesciences (EW – Research Report), BioMarin Pharmaceuti...

Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), BioMarin Pharmaceutical (BMRN) and Hookipa Pharma (HOOK)

HOOKIPA Pharma GAAP EPS of $0.11

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
HOOKIPA Pharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/hook-stock-quote/">HOOK</a>) just reported results for the first quarter of 2024.<ul><li>HOOKIPA Pharma reported earnings per share of 11 cents. This was above the analyst estimate for EPS of -10 cents.</li><li>The company reported revenue of $36.60 million.</li><li>This was 1,207.11% better than the analyst estimate for revenue of $2.80 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/hook-stock-earnings-hookipa-pharma-for-q1-of-2024/">HOOK Stock Earnings: HOOKIPA Pharma Beats EPS, Beats Revenue for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

HOOK Stock Earnings: HOOKIPA Pharma Beats EPS, Beats Revenue for Q1 2024

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Hookipa Pharma (HOOK – Research Report) and Femasys ...

Analysts Offer Insights on Healthcare Companies: Hookipa Pharma (HOOK) and Femasys (FEMY)

In a report released yesterday, Brian Abrahams from RBC Capital initiated coverage with a Buy rating on Hookipa Pharma (HOOK – Research Report) and...

-

-

-

-

-

-

-

-

-

-

-

-

-

-

HOOKIPA Pharma Stock (NASDAQ:HOOK), Short Interest Report

People Also Watch